{"id":"https://openalex.org/W4417010089","doi":"https://doi.org/10.1182/blood-2025-7539","title":"Requirements for achievement of treatment-free remission in long-term survivor of multiple myeloma","display_name":"Requirements for achievement of treatment-free remission in long-term survivor of multiple myeloma","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W4417010089","doi":"https://doi.org/10.1182/blood-2025-7539"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2025-7539","doi":"https://doi.org/10.1182/blood-2025-7539","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2025-7539","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086986826","display_name":"Masataka Takeshita","orcid":"https://orcid.org/0000-0003-2140-4007","observed_orcids":["https://orcid.org/0000-0003-2140-4007"]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masataka Takeshita","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]},{"raw_affiliation_string":"2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085115768","display_name":"Nobuyuki Kodama","orcid":"https://orcid.org/0000-0002-5279-029X","observed_orcids":["https://orcid.org/0000-0002-5279-029X"]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuyuki Kodama","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]},{"raw_affiliation_string":"2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025585656","display_name":"Tomoko Hishima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoko Hishima","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]},{"raw_affiliation_string":"2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055701247","display_name":"Hiroshi Suzuki","orcid":"https://orcid.org/0000-0002-8698-7357","observed_orcids":["https://orcid.org/0000-0002-8698-7357"]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Suzuki","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060716041","display_name":"Chigusa Kitayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chigusa Kitayama","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082637972","display_name":"Risen Hirai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Risen Hirai","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102825840","display_name":"Akira Tanimura","orcid":"https://orcid.org/0000-0003-0394-7032","observed_orcids":["https://orcid.org/0000-0003-0394-7032"]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Tanimura","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063794303","display_name":"Seishi Ogawa","orcid":"https://orcid.org/0000-0002-7778-5374","observed_orcids":["https://orcid.org/0000-0002-7778-5374"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seishi Ogawa","raw_affiliation_strings":["3Kyoto University, Department of Pathology and Tumor Biology, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Kyoto University, Department of Pathology and Tumor Biology, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066055908","display_name":"Yasuhito Nannya","orcid":"https://orcid.org/0000-0002-6526-0992","observed_orcids":["https://orcid.org/0000-0002-6526-0992"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhito Nannya","raw_affiliation_strings":["4Institute of Medical Science, University of Tokyo, Department of Hematology/Oncology, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institute of Medical Science, University of Tokyo, Department of Hematology/Oncology, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090736191","display_name":"Akiyoshi Miwa","orcid":"https://orcid.org/0009-0007-5668-8552","observed_orcids":["https://orcid.org/0009-0007-5668-8552"]},"institutions":[{"id":"https://openalex.org/I4210111769","display_name":"Tokyo-Kita Medical Center","ror":"https://ror.org/01swdcs64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111769"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiyoshi Miwa","raw_affiliation_strings":["1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tokyo-Kita Medical Center, Hematology, Kita-City, Japan","institution_ids":["https://openalex.org/I4210111769"]},{"raw_affiliation_string":"2International Myeloma Center for Advanced Research and Treatment, Kita-City, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Supplement 1","first_page":"7539","last_page":"7539"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/treatment-free-remission","display_name":"treatment-free remission","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hla-haplotypes","display_name":"HLA haplotypes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/host-immune-factors","display_name":"host immune factors","score":0.6000000238418579},{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.7649999856948853},{"id":"https://openalex.org/keywords/asxl1","display_name":"ASXL1","score":0.5860000252723694},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":0.9769999980926514},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8680999875068665},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7821000218391418},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.7045000195503235},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.527899980545044},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.5156000256538391},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.460099995136261},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4474000036716461},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42559999227523804},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4235000014305115},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.3675999939441681},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.3675000071525574},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.34470000863075256},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.32330000400543213},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31470000743865967},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.3019999861717224},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.3012999892234802},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.29190000891685486},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.2782999873161316},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2768999934196472},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.26570001244544983},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25999999046325684},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25200000405311584}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2025-7539","doi":"https://doi.org/10.1182/blood-2025-7539","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2025-7539","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3158614160","https://openalex.org/W4405042197","https://openalex.org/W4410809223","https://openalex.org/W4410439485","https://openalex.org/W4404603086","https://openalex.org/W4412521452","https://openalex.org/W4405092566","https://openalex.org/W2950009367","https://openalex.org/W4413111740","https://openalex.org/W4309190943"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Establishing":[2],"a":[3,11,19,310,515,566,584,601],"curative":[4],"strategy":[5],"for":[6,140,170,187,239,359,374,473,523,590],"multiple":[7,212],"myeloma":[8,501,524],"(MM)":[9],"remains":[10],"significant":[12,441,462],"challenge.":[13],"While":[14,476],"cure":[15,602],"is":[16,103,329,486,521],"defined":[17],"as":[18,270,423,556],"sustained":[20],"disease-free":[21,49,67,95],"remission":[22,169,186,196,238,356,384],"after":[23,190,221],"treatment":[24,52,70,353],"discontinuation,":[25,354],"not":[26,357],"all":[27],"patients":[28,44,111,136,166,382,433],"still":[29],"achieve":[30,397],"this":[31,91,126,307,323,327,552,616],"outcome.":[32],"However,":[33,378,416],"recent":[34],"results":[35,564],"with":[36,42,61,98,112,177,211,225,342,364,385,464],"CAR-T":[37,79],"therapy":[38,80],"offer":[39],"considerable":[40],"promise,":[41],"some":[43],"experiencing":[45],"long-term":[46,114,375,380],"(5+":[47],"years)":[48],"survival":[50,344],"following":[51,195],"completion":[53],"(Voorhees":[54],"PM.":[55],"ASCO2025":[56],"#7507).":[57],"Conversely,":[58],"conventional":[59],"therapies":[60],"novel":[62],"agents":[63],"have":[64,545],"shown":[65],"limited":[66],"intervals,":[68],"and":[69,143,145,198,215,227,256,286,480,494,508,525,574],"interruptions":[71],"often":[72],"lead":[73],"to":[74,90,105,119,249,276,289,299,396,451,547,600],"relapse.":[75],"The":[76,181],"mechanism":[77],"of":[78,125,322,338,403,430,446,500,551,572,577,608,615],"suggests":[81],"that":[82,336,369,410],"anti-tumor":[83],"effects":[84],"by":[85,533],"MM-targeted":[86],"T":[87],"cells":[88],"contribute":[89],"prolonged":[92],"remission.":[93,115],"Extended":[94],"intervals":[96],"correlate":[97],"improved":[99],"outcomes.":[100],"Therefore,":[101,294,390],"it":[102],"crucial":[104],"identify":[106],"the":[107,122,207,301,320,413,444,447,467,481,483,497,510,540,548,570,575,597,606],"underlying":[108],"factors":[109,247,392],"in":[110,267,306,316,325,383,435,443,478,489,502,506,527,554,603],"such":[113,269,609],"This":[116,233,542,593],"study":[117],"aims":[118],"comprehensively":[120],"analyze":[121],"genetic":[123,157],"background":[124,426],"patient":[127,183,209,234,585,617],"subgroup.":[128,618],"Methods":[129],"We":[130,245,582],"analyzed":[131],"282":[132],"newly":[133],"diagnosed":[134],"MM":[135,277,432],"retrospectively":[137],"(National":[138],"Center":[139],"Global":[141],"Health":[142],"Medicine":[144],"Tokyo-Kita":[146],"Medical":[147],"Center,":[148],"2007-2025).":[149],"Clinical":[150],"specimens":[151],"from":[152,253],"our":[153,161,404,465],"institutional":[154],"biobank":[155],"underwent":[156],"analysis.":[158],"Results":[159],"Among":[160],"cohort,":[162],"we":[163,295,611],"identified":[164,422,583],"two":[165],"who":[167],"maintained":[168,184,237],"10+":[171,591],"years":[172,189,241],"despite":[173],"discontinuing":[174,191],"anti-MM":[175,243],"treatment,":[176],"contrasting":[178],"clinical":[179,251,414,436,594],"courses.":[180],"first":[182],"treatment-free":[185],"14":[188],"thalidomide":[192],"(Thal)":[193],"maintenance,":[194],"induction":[197],"tandem":[199,222],"autologous":[200],"stem":[201],"cell":[202],"transplantation":[203],"(ASCT).":[204],"In":[205,259],"contrast,":[206],"second":[208],"presented":[210],"bone":[213],"lesions":[214],"primary":[216],"refractoriness.":[217],"Despite":[218],"aggressive":[219],"recurrence":[220],"ASCT,":[223],"salvage":[224],"VTD-PACE":[226],"an":[228,424],"additional":[229,391],"ASCT":[230],"proved":[231],"effective.":[232],"has":[235],"since":[236],"12":[240],"without":[242],"treatment.":[244],"investigated":[246],"dedicated":[248],"their":[250],"courses,":[252],"both":[254,260],"tumor":[255],"host":[257,302],"background.":[258],"cases,":[261,610],"Whole-exome":[262],"sequencing":[263],"revealed":[264,406],"no":[265,407,440],"mutations":[266,409],"genes":[268],"KRAS,":[271],"MYC,":[272],"or":[273],"TP53,":[274],"related":[275],"progression":[278],"(Bolli":[279],"N.":[280],"Nat":[281],"Commun":[282],"2014;5:2997),":[283],"nor":[284],"ASXL1":[285],"TET2,":[287],"leading":[288],"CHIP":[290],"(Lionetti":[291],"M.":[292,455],"Blood2023;146(5):571).":[293],"performed":[296],"HLA":[297],"typing":[298],"investigate":[300],"immune":[303,531,579],"factors.":[304],"Patients":[305],"subgroup":[308,586],"shared":[309],"haplotype":[311,324,417,449,469,485,512],"containing":[312],"HLA-B*46,":[313,420],"predominantly":[314],"distributed":[315],"East":[317,490,503],"Asia.":[318,528],"Given":[319,605],"frequency":[321,550],"Japan,":[326],"result":[328],"considered":[330],"statistically":[331],"significant.":[332],"Discussion":[333],"Dimopoulos":[334],"reported":[335,557],"usage":[337],"Thal":[339,351,370,520,573],"was":[340,421],"associated":[341],"Ultra-Long-Term":[343],"(ASH2024":[345],"#1948).":[346],"Our":[347],"cases":[348,405],"also":[349,363],"received":[350],"before":[352],"maintaining":[355,474],"only":[358],"Long-Term":[360],"(LT)":[361],"but":[362],"Treatment-Free":[365,386,399,588],"status.":[366],"These":[367,563],"suggest":[368,565],"may":[371,470,544],"be":[372,471],"effective":[373],"disease":[376],"control.":[377],"among":[379],"survivors,":[381],"are":[387,393],"extremely":[388],"rare.":[389],"likely":[394],"necessary":[395],"LT":[398],"R.":[400],"Genomic":[401],"analysis":[402,614],"tumor-specific":[408],"could":[411],"explain":[412],"course.":[415],"sharing,":[418],"including":[419,492],"immunological":[425],"factor.":[427],"A":[428],"cohort":[429],"Japanese":[431],"enrolled":[434],"trial":[437],"(JCOG1105)":[438],"showed":[439],"difference":[442],"prevalence":[445],"HLA-B*46":[448,468,484,511,534],"compared":[450],"healthy":[452],"individuals":[453],"(Ri":[454],"Cancer":[456],"Sci":[457],"112(12)5011).":[458],"Nevertheless,":[459],"given":[460],"its":[461],"association":[463],"subgroup,":[466],"essential":[472],"LT-TFR.":[475],"rare":[477],"Europe":[479],"US,":[482],"relatively":[487],"frequent":[488],"Asia,":[491,555],"Japan":[493],"China.":[495],"Considering":[496],"lower":[498],"incidence":[499],"Asia":[504],"than":[505,539],"Africa":[507],"Europe,":[509],"might":[513],"confer":[514],"protective":[516],"effect":[517,543],"against":[518],"myeloma.":[519],"approved":[522],"leprosy":[526],"Regarding":[529],"leprosy,":[530],"surveillance":[532],"allele":[535,553],"provides":[536],"greater":[537],"protection":[538],"others.":[541],"contributed":[546],"increased":[549],"(Hilton":[558],"HG.":[559],"Cell":[560],"Rep.":[561],"2017;19(7):1394).":[562],"potential":[567],"correlation":[568],"between":[569],"efficacy":[571],"coverage":[576],"specific":[578],"surveillance.":[580],"Conclusion":[581],"achieving":[587],"Remission":[589],"years.":[592],"status":[595],"represents":[596],"closest":[598],"approximation":[599],"MM.":[604],"rarity":[607],"need":[612],"further":[613]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-12-04T00:00:00"}